Senator Grassley seeks info on Novartis’s Zolgensma data issues
FILE PHOTO: U.S. Senator Chuck Grassley (R-IA) speaks to reporters on his way from the Senate floor after a vote at the U.S. Capitol in Washington, U.S. May 14, 2019.…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to the U.S. health regulator regarding an ongoing study of the…
Patient groups push back against Gilead’s pricey HIV prevention treatment
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker…
Nobio gets FDA approval for anti-bacterial dental fillings
TEL AVIV (Reuters) – Israel’s Nobio Ltd said on Monday it received approval from the U.S. Food and Drug Administration to market its anti-bacterial composite designed to remain in the…
Roche says test showed Tecentriq helped vs bladder cancer
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Roche Holding said its Tecentriq drug…
U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor
(Reuters) – The U.S. Food and Drug Administration on Friday approved Daiichi Sankyo Co Ltd’s treatment for adult patients with a type of rare, non-cancerous tumor affecting joints and limbs.…
Oklahoma makes final bid to hold J&J responsible for opioid epidemic
(Reuters) – Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion for its part in fueling the opioid epidemic, saying the…
Bernie Sanders visits Canadian pharmacy, talks drug prices
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the border on Sunday to buy cheap insulin in Canada, highlighting…